Patents by Inventor Ruth Marron

Ruth Marron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of multiple sclerosis using COP-1 and Th2-enhancing cytokines
    Publication number: 20010007758
    Abstract: The invention relates to a treatment for multiple sclerosis. COP-1 (copolymer-1), a synthetic polymer consisting of a mixture of random synthetic polypeptides composed of L-alanine, L-glutamic acid, L-lysine and L-tyrosine in a molar ratio of about 6:2:5:1, is administered mucosally to patients afflicted with the disease in combination with Th2 enhancing cytokines such as IL-4 or IL-10. The combination treatment of IL-4 or IL-10 (preferably orally administered) with mucosally administered COP-1 shows a substantially greater suppressive effect than does treatment with cytokine or COP-1 alone.
    Type: Application
    Filed: February 6, 2001
    Publication date: July 12, 2001
    Applicant: Autoimmune, Inc.
    Inventors: Howard L. Weiner, Ruth Marron, Anthony Slavin